News | April 10, 2026
Lupin Foundation expands NCD care access in Rajasthan with new diagnostic corners
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21
Approval for 5 mg and 10 mg strengths, bioequivalent to Farxiga®, strengthens Lupin’s anti-diabetic portfolio in US market
Benzonatate is a non-narcotic antitussive that numbs stretch receptors in the respiratory tract
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
Vapendavir is an oral, potent, broad-spectrum antiviral active against rhinoviruses and related respiratory enteroviruses
Esprit is a multicenter, randomized, placebo-controlled, double-blind study assessing the safety, pharmacodynamics, and preliminary efficacy of S-606001 as a substrate reduction therapy
India faces a significant and growing burden of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease
LTTS’ lung digital twin integrates seamlessly with CT imaging workflows, using deep learning to reconstruct a comprehensive 3D digital twin of the lungs
The approval means US laboratories can now run both respiratory and gastrointestinal panels on the high-throughput QIAstat-Dx Rise
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
